Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Edwards Lifesciences (NY: EW )

88.01 -0.60 (-0.68%)
Official Closing Price Updated: 7:00 PM EDT, Apr 25, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 4,295,298
Open 88.00
Bid (Size) 85.50 (12)
Ask (Size) 91.22 (1)
Prev. Close 88.61
Today's Range 86.66 - 88.73
52wk Range 60.57 - 95.73
Shares Outstanding 601,100,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
EW Stock Earnings: Edwards Lifesciences Beats EPS, Beats Revenue for Q1 2024
EW stock results show that Edwards Lifesciences beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
Edwards Lifesciences Nabs Quarterly Beat And Plans A 'Critical' Spinoff
The company also raised its outlook for the year and now expects 8% to 10% sales growth. 
Via Investor's Business Daily

Performance

YTD
+16.46%
+16.46%
1 Month
-5.79%
-5.79%
3 Month
+19.66%
+19.66%
6 Month
+40.19%
+40.19%
1 Year
+0.69%
+0.69%

More News

Read More
Edwards Lifesciences Reports First Quarter Results
From Edwards Lifesciences Corporation
Via Business Wire
Decoding Edwards Lifesciences's Options Activity: What's the Big Picture?
Via Benzinga
Behind the Scenes of Edwards Lifesciences's Latest Options Trends
Via Benzinga
Edwards Lifesciences to Host Earnings Conference Call on April 25, 2024
From Edwards Lifesciences Corporation
Via Business Wire
$1000 Invested In Edwards Lifesciences 15 Years Ago Would Be Worth This Much Today
Via Benzinga
How Is The Market Feeling About Edwards Lifesciences?
Via Benzinga
What Analysts Are Saying About Edwards Lifesciences Stock
Via Benzinga
The 5 Stocks Most Sold By Insiders This Year
Via MarketBeat
Study of NFL Alumni Cohort Finds Majority Suffer From Heart Disease Without Knowing It
From Edwards Lifesciences Corporation
Via Business Wire
$100 Invested In Edwards Lifesciences 10 Years Ago Would Be Worth This Much Today
Via Benzinga
The Latest Analyst Ratings For Edwards Lifesciences
Via Benzinga
Edwards Lifesciences Stock Earns Relative Strength Rating Upgrade; Hits Key Benchmark
Via Investor's Business Daily
What 9 Analyst Ratings Have To Say About Edwards Lifesciences
Via Benzinga
Looking Into Edwards Lifesciences's Recent Short Interest
Via Benzinga
$100 Invested In This Stock 20 Years Ago Would Be Worth $3,200 Today
Via Benzinga
Here's How Much You Would Have Made Owning Edwards Lifesciences Stock In The Last 15 Years
Via Benzinga
Large, Real-world Studies Demonstrate Continued Excellent Outcomes for Patients Receiving Edwards SAPIEN TAVR
From Edwards Lifesciences Corporation
Via Business Wire
Edwards Lifesciences to Present at the 44th Annual TD Cowen Healthcare Conference
From Edwards Lifesciences Corporation
Via Business Wire
Here's How Much You Would Have Made Owning Edwards Lifesciences Stock In The Last 15 Years
Via Benzinga
FDA Advisors Set To Discuss Abbott's TriClip For Heart Valve Disorder As Questions On Pivotal Trial Loom
Via Benzinga
Exposures Product Safety
Can financial, healthcare, energy stocks rise as rates stay high?
Via MarketBeat
These Analysts Boost Their Forecasts On Edwards Lifesciences Following Q4 Results
Via Benzinga
Edwards Lifesciences Dips On In-Line Profit, Narrow Sales Beat
Via Investor's Business Daily
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.